VANIQA
Google image searchProduct monograph
Active ingredient
eflornithine hydrochloride, 13.9 %/W/W
DIN: 02243837
Dosage form(s): CREAM
Route(s) of administration: TOPICAL
Schedule: Prescription
Company: CIPHER PHARMACEUTICALS INC
Date: 04-DEC-2015
ATC:
- D11 — OTHER DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD, )
- D11A — OTHER DERMATOLOGICAL PREPARATIONS (ATC, ATC/DDD)
- D11AX — Other dermatologicals (ATC, ATC/DDD)
- D11AX16 — EFLORNITHINE (ATC/DDD)
Reference brand drug: Vaniqa
